Use of flunarizine and method for controlling number of intercellular mitochondria
US-2024325381-A1 · Oct 3, 2024 · US
Drug screening
Drug screening · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12N2503/02 |
| Official title | Drug screening |
| Display label | Drug screening |
| Total patents | 663 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 36 |
| 2016 | 45 |
| 2017 | 44 |
| 2018 | 55 |
| 2019 | 64 |
| 2020 | 66 |
| 2021 | 61 |
| 2022 | 61 |
| 2023 | 72 |
| 2024 | 73 |
| 2025 | 66 |
| 2026 | 20 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Systems and methods for measuring cell signaling protein activity
US-2024230643-A9 · Jul 11, 2024 · US
Cardiomyocyte maturation
US-11920158-B2 · Mar 5, 2024 · US
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US-2016339019-A1 · Nov 24, 2016 · US
Isolation and use of solid tumor stem cells
US-9492538-B2 · Nov 15, 2016 · US
Method for obtaining pancreatic endocrine cells from adipose tissue-origin cells
US-2016312188-A1 · Oct 27, 2016 · US
Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
US-9469653-B2 · Oct 18, 2016 · US
Pluripotent cell lines and methods of use thereof
US-9464273-B2 · Oct 11, 2016 · US
Immortalization of Epithelial Cells and Methods of Use
US-2016289644-A1 · Oct 6, 2016 · US
HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS)
US-2016257937-A1 · Sep 8, 2016 · US
Methods for generating 3d cell culture model in high respiration environments for high-content analyses and screening
US-2016215267-A1 · Jul 28, 2016 · US
Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof
US-9395354-B2 · Jul 19, 2016 · US
Human pluripotent stem cell-based models for predictive developmental neural toxicity
US-2016186146-A1 · Jun 30, 2016 · US
Human pluripotent stem cell-based system for generating endothelial cells
US-2016186135-A1 · Jun 30, 2016 · US
Cell culture kit, screening method, and method of manufacturing cell culture kit
US-2016160175-A1 · Jun 9, 2016 · US
Scaffolds for Soft Tissue and Uses Thereof
US-2016128818-A1 · May 12, 2016 · US
Compounds for improved stem cell differentiation into hepatocytes
US-9334480-B2 · May 10, 2016 · US
TAZ/WWTR1 for diagnosis and treatment of cancer
US-9316654-B2 · Apr 19, 2016 · US
Blood-cell producing bio-microreactor
US-2016097033-A1 · Apr 7, 2016 · US
Collecting ovarian cancer stem cells from ovarian cancer cells
US-9289492-B2 · Mar 22, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C12N2503/02?
- CPC C12N2503/02 is the Cooperative Patent Classification code for “Drug screening.”
- How many patents are filed under CPC C12N2503/02 (Drug screening)?
- Our database includes 663 publications tagged with this CPC code.
- Is patent activity under CPC C12N2503/02 growing?
- Publication counts under this code: 73 in 2024 vs 66 in 2025 (latest complete years).